Study of CB-5339 in Acute Myeloid Leukemia or Myelodysplastic Syndrome
Conditions: Acute Myeloid Leukemia, in Relapse; Myelodysplastic Syndromes Intervention: Drug: CB-5339 Sponsor: Cleave Therapeutics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acute Leukemia | Acute Myeloid Leukemia | Leukemia | Myelodysplastic Syndrome | Research | Study